vs
杜比实验室(DLB)与Healthpeak Properties(DOC)财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是杜比实验室的1.8倍($719.4M vs $395.6M),Healthpeak Properties净利率更高(73.2% vs 24.0%,领先49.2%),杜比实验室同比增速更快(7.1% vs 3.1%),过去两年杜比实验室的营收复合增速更高(13.9% vs 8.9%)
杜比实验室是一家美国科技企业,专注于音频降噪、音频编码压缩、空间音频及高动态范围(HDR)影像等技术的研发,旗下技术广泛授权给全球各地的消费电子制造商使用,助力终端产品为用户带来更出色的视听体验。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
DLB vs DOC — 直观对比
营收规模更大
DOC
是对方的1.8倍
$395.6M
营收增速更快
DLB
高出4.0%
3.1%
净利率更高
DOC
高出49.2%
24.0%
两年增速更快
DLB
近两年复合增速
8.9%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $395.6M | $719.4M |
| 净利润 | $94.9M | $114.0M |
| 毛利率 | 88.7% | — |
| 营业利润率 | 28.5% | 17.4% |
| 净利率 | 24.0% | 73.2% |
| 营收同比 | 7.1% | 3.1% |
| 净利润同比 | 3.4% | 2406.4% |
| 每股收益(稀释后) | $0.99 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DLB
DOC
| Q2 26 | $395.6M | — | ||
| Q1 26 | $346.7M | — | ||
| Q4 25 | $346.7M | $719.4M | ||
| Q3 25 | $307.0M | $705.9M | ||
| Q2 25 | $315.5M | $694.3M | ||
| Q1 25 | $369.6M | $702.9M | ||
| Q4 24 | $357.0M | $698.0M | ||
| Q3 24 | $304.8M | $700.4M |
净利润
DLB
DOC
| Q2 26 | $94.9M | — | ||
| Q1 26 | $53.3M | — | ||
| Q4 25 | $53.3M | $114.0M | ||
| Q3 25 | $49.3M | $-117.1M | ||
| Q2 25 | $46.1M | $31.7M | ||
| Q1 25 | $91.8M | $42.8M | ||
| Q4 24 | $67.8M | $4.5M | ||
| Q3 24 | $58.6M | $85.9M |
毛利率
DLB
DOC
| Q2 26 | 88.7% | — | ||
| Q1 26 | 87.5% | — | ||
| Q4 25 | 87.5% | — | ||
| Q3 25 | 87.1% | 58.6% | ||
| Q2 25 | 86.1% | 60.2% | ||
| Q1 25 | 90.3% | 61.1% | ||
| Q4 24 | 88.6% | 60.3% | ||
| Q3 24 | 88.8% | 60.0% |
营业利润率
DLB
DOC
| Q2 26 | 28.5% | — | ||
| Q1 26 | 17.9% | — | ||
| Q4 25 | 17.9% | 17.4% | ||
| Q3 25 | 9.7% | 9.2% | ||
| Q2 25 | 15.1% | 5.7% | ||
| Q1 25 | 29.2% | 7.7% | ||
| Q4 24 | 22.4% | -2.2% | ||
| Q3 24 | 15.2% | 14.1% |
净利率
DLB
DOC
| Q2 26 | 24.0% | — | ||
| Q1 26 | 15.4% | — | ||
| Q4 25 | 15.4% | 73.2% | ||
| Q3 25 | 16.1% | -16.6% | ||
| Q2 25 | 14.6% | 4.6% | ||
| Q1 25 | 24.8% | 6.1% | ||
| Q4 24 | 19.0% | 0.7% | ||
| Q3 24 | 19.2% | 12.3% |
每股收益(稀释后)
DLB
DOC
| Q2 26 | $0.99 | — | ||
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.55 | $0.16 | ||
| Q3 25 | $0.50 | $-0.17 | ||
| Q2 25 | $0.48 | $0.05 | ||
| Q1 25 | $0.94 | $0.06 | ||
| Q4 24 | $0.70 | $0.02 | ||
| Q3 24 | $0.59 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $594.7M | $467.5M |
| 总债务越低越好 | — | $9.8B |
| 股东权益账面价值 | $2.6B | $7.5B |
| 总资产 | $3.2B | $20.3B |
| 负债/权益比越低杠杆越低 | — | 1.31× |
8季度趋势,按日历期对齐
现金及短期投资
DLB
DOC
| Q2 26 | $594.7M | — | ||
| Q1 26 | $644.6M | — | ||
| Q4 25 | $644.6M | $467.5M | ||
| Q3 25 | $702.6M | $91.0M | ||
| Q2 25 | $699.3M | $89.4M | ||
| Q1 25 | $626.6M | $70.6M | ||
| Q4 24 | $520.8M | $119.8M | ||
| Q3 24 | $482.0M | $180.4M |
总债务
DLB
DOC
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $9.8B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B |
股东权益
DLB
DOC
| Q2 26 | $2.6B | — | ||
| Q1 26 | $2.6B | — | ||
| Q4 25 | $2.6B | $7.5B | ||
| Q3 25 | $2.6B | $7.6B | ||
| Q2 25 | $2.6B | $7.9B | ||
| Q1 25 | $2.6B | $8.2B | ||
| Q4 24 | $2.5B | $8.4B | ||
| Q3 24 | $2.5B | $8.6B |
总资产
DLB
DOC
| Q2 26 | $3.2B | — | ||
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $20.3B | ||
| Q3 25 | $3.2B | $19.6B | ||
| Q2 25 | $3.2B | $19.8B | ||
| Q1 25 | $3.2B | $19.8B | ||
| Q4 24 | $3.2B | $19.9B | ||
| Q3 24 | $3.1B | $20.0B |
负债/权益比
DLB
DOC
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $147.3M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | — | $357.0M |
| 自由现金流率自由现金流/营收 | — | 49.6% |
| 资本支出强度资本支出/营收 | — | 124.4% |
| 现金转化率经营现金流/净利润 | 1.55× | 10.99× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
DLB
DOC
| Q2 26 | $147.3M | — | ||
| Q1 26 | $54.8M | — | ||
| Q4 25 | $54.8M | $1.3B | ||
| Q3 25 | $472.2M | $315.0M | ||
| Q2 25 | $67.7M | $363.5M | ||
| Q1 25 | $174.9M | $279.4M | ||
| Q4 24 | $106.8M | $1.1B | ||
| Q3 24 | $327.3M | $318.2M |
自由现金流
DLB
DOC
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $50.2M | $357.0M | ||
| Q3 25 | $435.9M | — | ||
| Q2 25 | $61.3M | — | ||
| Q1 25 | $168.0M | — | ||
| Q4 24 | $100.0M | $333.7M | ||
| Q3 24 | $297.2M | — |
自由现金流率
DLB
DOC
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 14.5% | 49.6% | ||
| Q3 25 | 142.0% | — | ||
| Q2 25 | 19.4% | — | ||
| Q1 25 | 45.5% | — | ||
| Q4 24 | 28.0% | 47.8% | ||
| Q3 24 | 97.5% | — |
资本支出强度
DLB
DOC
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | 124.4% | ||
| Q3 25 | 11.8% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 1.9% | 105.6% | ||
| Q3 24 | 9.8% | — |
现金转化率
DLB
DOC
| Q2 26 | 1.55× | — | ||
| Q1 26 | 1.03× | — | ||
| Q4 25 | 1.03× | 10.99× | ||
| Q3 25 | 9.57× | — | ||
| Q2 25 | 1.47× | 11.48× | ||
| Q1 25 | 1.91× | 6.52× | ||
| Q4 24 | 1.57× | 235.43× | ||
| Q3 24 | 5.59× | 3.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DLB
| Licensing | $372.2M | 94% |
| Products and services | $23.4M | 6% |
DOC
暂无分部数据